A Randomized, Phase III of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan Versus Trastuzumab, Chemothe...
Urothelial
22
Jul
A Randomized Open-Label Phase 2/3 Study of BT8009 as Monotherapy or in Combination in Participants with Locally Advanced or Metastati...
All Site
28
Dec
An Open Label, Multicenter Safety and Efficacy Phase II/III Study of PRL3-Zumab in Solid Tumors Patients
Solid tumor
Beacon Hospi...
Hemato-Oncology
28
Dec
A Randomized, Open-Label, Multicenter, Phase 3 Study of Zilovertamab Vedotin (MK-2140) in Combination With R-CHP Versus R-CHOP in Par...
Others
12
Nov
Development and Validation of Blood-Based Predictive Biomarkers for Response to PD-1/PD-L1 Checkpoint Inhibitors: Evidence of a Unive...
Lung Cancer
23
Sep
Plasma Molecular Profiling in ALK inhibitor resistant non-small cell lung cancer (ARTOG-004)
Non Small Cell Lung Cancer with ALK Inh...
Rare Cancers
23
Sep
Promoting genomic medicine throughout Asia (MASTER KEY ASIA)
University of Malaya Medical Centre (UMMC)
PRINCIPAL INVESTIGATOR
D...
Nasopharyngeal Carcinoma
23
Sep
Asian multicenter prospective study of circulating tumor DNA sequencing (A-TRAIN Nasopharyngeal Carcinoma Project)
Nasopharyngeal Ca...
Cervical Cancer Ovarian Clear Cell Carcinoma N
23
Sep
Asian Multicenter Prospective Study of Circulating Tumor DNA Sequencing (A-TRAIN)
Metastatic and/or Recurrent Disease
University ...
Prostate Cancer
23
Sep
Biomarker Study to Determine Frequency of DNA-repair Defects in Men with Metastatic Prostate Cancer (Observational) (PREVALENCE)
Met...